GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alnylam Pharmaceuticals ALNY · USD

Health Care · Biotechnology · US listing · 🇺🇸 United States

Nasdaq-100

Compare

156.61

+0.43%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Alnylam Pharmaceuticals and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Alnylam Pharmaceuticals ALNY 156.61$20.96bn67.88.4%— +0.43%
Teva Pharma Industries Ltd ADR TEVA 42.97$50.04bn34.48.2%— +0.84%
Haleon plc HLN 8.97$39.60bn24.315.1%— -1.86%
Edwards Lifesciences EW 104.71$61.34bn55.117.7%— +2.52%
Resmed RMD 235.74$34.73bn23.326.9%1.02% +0.19%
Zoetis ZTS 82.32$36.54bn14.828.2%2.38% +3.68%
GE Healthcare Technologies GEHC 84.03$38.49bn18.310.1%0.17% +2.00%
Amerisourcebergen ABC ————— —
Becton Dickinson and Co BDX 215.25$62.10bn36.07.7%2.01% +1.59%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.